Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.

Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.

The aim of the present study was to characterize the expression pattern of tumor necrosis factor (TNF)-alpha and its receptors (TNF-Rs) in the epithelial ovarian cancer (EOC) and compare these results with the outcome of 126 patients. Presence of TNF-alpha, TNFR-1 and TNFR-2 were studied by Western...

Full description

Bibliographic Details
Main Authors:	Jacek Nikliński, Piotr S Bernaczyk, Wieslawa Niklińska, Magdalena Garbowicz, Slawomir J Terlikowski, Bozena Dobrzycka, Maciej Kinalski, Lech Chyczewski
Format:	Article
Language:	English
Published:	Via Medica 2010-05-01
Series:	Folia Histochemica et Cytobiologica
Online Access:	http://czasopisma.viamedica.pl/fhc/article/view/4312

Similar Items

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
by: Bozena Dobrzycka, et al.
Published: (2010-04-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
by: Magdalena Garbowicz, et al.
Published: (2011-04-01)

Mutations in the KRAS gene in ovarian tumors.
by: Wiesława Niklińska, et al.
Published: (2009-12-01)

Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
by: Wiesława Niklińska, et al.
Published: (2009-05-01)

Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes
by: Bozena Dobrzycka, et al.
Published: (2024-01-01)

Immunohistochemical markers of cancerogenesis in the lung.
by: Lech Chyczewski, et al.
Published: (2007-06-01)

Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer
by: Katarzyna M. Terlikowska, et al.
Published: (2020-09-01)

Quality of life in long-term survivors of early stage endometrial cancer
by: Bożena Dobrzycka, et al.
Published: (2017-09-01)

Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer.
by: Lech Chyczewski, et al.
Published: (2008-02-01)

Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment
by: Katarzyna M. Terlikowska, et al.
Published: (2021-03-01)

Detection of DNA methylation in eucaryotic cells.
by: Lech Chyczewski, et al.
Published: (2008-01-01)

DNA methylation in states of cell physiology and pathology.
by: Lech Chyczewski, et al.
Published: (2007-10-01)

Biomarkers as prognostic factors in endometrial cancer.
by: Sławomir J Terlikowski, et al.
Published: (2010-11-01)

Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.
by: Lech Chyczewski, et al.
Published: (2007-10-01)

Bone as a source of organism vitality and regeneration
by: Jolanta Kowalewska, et al.
Published: (2012-01-01)

Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer
by: Lech Chyczewski, et al.
Published: (2011-07-01)

HIF-1 expression in retinal ganglion cells and optic nerve axons in glaucoma HIF-1 expression in retinal ganglion cells and optic nerve axons in glaucoma
by: Joanna Reszeć, et al.
Published: (2012-10-01)

Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non–Small Cell Lung Cancer
by: Oksana Kowalczuk, et al.
Published: (2014-10-01)

Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
by: Lech Chyczewski, et al.
Published: (2009-01-01)

The evaluation of human papillomavirus and p53 gene mutation in benign and malignant conjunctiva and eyelid lesions.
by: Skawronska Małgorzata, et al.
Published: (2011-04-01)

The evaluation of human papillomavirus and p53 gene mutation in benign and malignant conjunctiva and eyelid lesions.
by: Reszec Joanna, et al.
Published: (2010-04-01)

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
by: Zheng, R, et al.
Published: (1992)

Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC
by: Radoslaw Charkiewicz, et al.
Published: (2017-06-01)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
by: Grażyna Ewa Będkowska, et al.
Published: (2017-06-01)

Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome
by: Miaad Jabbar Alhilali, et al.
Published: (2020-11-01)

The relationship of mast cell density in pulmonary, gastric and ovarian malignant epithelial tumors with tumor necrosis and vascularization
by: Şeyhmus Kaya, et al.
Published: (2020-10-01)

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges
by: Patrycja Aleksandra Bukłaho, et al.
Published: (2023-09-01)

Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells
by: W. Cui, et al.
Published: (2010-04-01)

Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
by: Lech Chyczewski, et al.
Published: (2009-01-01)

Polymorphism of tumor necrosis factor-alpha 308 G/A gene in Iraqi patients with polycystic ovarian syndrome
by: Fadhil Jawad Al-Tu’ma, et al.
Published: (2017-06-01)

Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progressionResearch in context
by: Donata Ponikwicka-Tyszko, et al.
Published: (2019-09-01)

Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies
by: Olimpia Sipak-Szmigiel, et al.
Published: (2017-04-01)

Tumor Necrosis Factor Alpha Effects on the Porcine Intestinal Epithelial Barrier Include Enhanced Expression of TNF Receptor 1
by: Linda Droessler, et al.
Published: (2021-08-01)

Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosis as an Attractive Theranostic Outlook for Tackling Non-Small Lung Cancer: A Mini Review
by: Joanna Pancewicz, et al.
Published: (2022-05-01)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
by: Kai You, et al.
Published: (2021-07-01)

Implication of Tumor Necrosis Factor - Alpha in Preeclampsia
by: Dan MIHU, et al.
Published: (2008-12-01)

Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
by: Koelen, J
Published: (2015)

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
by: Nirmala Chandralega Kampan, et al.
Published: (2017-11-01)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
by: Ulfgren, A, et al.
Published: (2000)

Tumor Necrosis Factor alpha receptors p55 and p75 and ovarian cancer – state-of-the-art research and clinical implications
by: Paweł Rzymski
Published: (2005-03-01)